BiotechTube
Quansys Biosciences

Quansys Biosciences

Logan, United States· Est.
quansysbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Quansys Biosciences is a specialized provider of multiplex immunoassay solutions for the life sciences research market. The company's proprietary Q-Plex™ platform, centered on printed microplate arrays and paired with its Q-View™ imagers and software, allows for the efficient analysis of multiple protein biomarkers from minimal sample volume. Quansys serves a global customer base of academic, pharmaceutical, and government researchers through off-the-shelf and custom assay kits, positioning itself as a cost-effective alternative to larger diagnostic and life science tools companies. Its business model combines product sales of consumable kits and capital equipment (imagers) with custom OEM development services.

DiagnosticsAntibodies

Technology Platform

Q-Plex™ multiplex ELISA platform utilizing printed antibody arrays on microplates, detected by chemiluminescence with dedicated Q-View™ imagers and analysis software.

Funding History

1
SeedUndisclosed

Opportunities

Growing demand for multiplex protein analysis in research creates a steady market.
The custom OEM development service allows the company to embed its technology in other firms' products, providing a scalable revenue channel.
The recent launch of an upgraded imager and software can drive sales of capital equipment and attract new users to the ecosystem.

Risk Factors

Intense competition from larger, established life science tools companies with broader portfolios and greater sales reach.
Technological disruption from newer, higher-plex or more sensitive assay platforms could erode the value proposition.
As a smaller private company, it may have limited resources for aggressive marketing and global expansion.

Competitive Landscape

Quansys competes in the multiplex immunoassay segment against major players like Luminex (acquired by DiaSorin), Meso Scale Discovery (MSD), and the assay divisions of large conglomerates (e.g., Thermo Fisher, Bio-Rad). Its key differentiators are a focused mid-plex offering, a complete integrated system (plate, imager, software), and a emphasis on cost-effectiveness. It also competes with numerous ELISA kit manufacturers by providing a multiplex alternative to singleplex testing.

More companies in Diagnostics & Precision Medicine →More companies in United States →